ALNY

143.8202.71%
BA

Bryan Andrew Supran

Chief Legal Officer

Mr. Bryan Andrew Supran J.D., is Chief Legal Officer of Alnylam Pharmaceuticals, Inc. from September 2025. Mr. Bryan Andrew Supran served as Non-Executive Director at Haleon plc until February 25, 2025 and served as its Independent Nominee Non-Executive Director since July 18, 2022. He has been Vice President of Icagen, Inc. since October 27, 2011. Mr. Supran has been Senior Vice President and Associate General Counsel of Pfizer Business Transactions since March 2011. He served as Vice President and Associate General Counsel of Pfizer's Legal Division from October 2009 to March 2011. He previously served as Vice President and Associate General Counsel at Wyeth from 2004 to 2009. Prior to joining Wyeth, he practiced at Ropes & Gray LLP in Boston and New York. He has been a Director of Medivation, Inc. since September 28, 2016. He has been a Director of Anacor Pharmaceuticals, Inc. since June 24, 2016. He serves as a Director at King Pharmaceuticals LLC (Alternate name, King Pharmaceuticals, Inc.). He served as Director of Icagen, Inc. since October 27, 2011. He serves as Director of Upjohn Inc.

Positions